Navigation Links
Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law
Date:8/7/2008

SACRAMENTO, Calif., Aug. 7 /PRNewswire-USNewswire/ -- Nurses, consumers, and seniors called on the legislature and the governor today to include a key provision to protect innocent patients in any health insurance cancellation legislation forthcoming in the closing days of the legislative session.

Over the last 5 years, California patients have been plagued by the practice of insurance companies retroactively canceling health insurance coverage after they get sick - so called "rescissions" - leaving patients without health care when they are sick and need it most. Cancelled patients are virtually uninsurable and often hundreds of thousands of dollars in debt while facing ongoing medical treatment.

"RNs see the damage done to patients every day by insurance companies," said Malinda Markowitz, RN and member of the council of presidents of the California Nurses Association. "Insurance companies should not be allowed to cancel the health care of innocent patients and the legislature should not allow the Governor to water down existing law to benefit his largest contributors."

In 2007, Governor Schwarzenegger's Administration promised to protect innocent patients from rescission in new regulations. Those regulations have stalled. Now, the governor's office has drafted legislative language that retreats from that promise and that would weaken existing law. The governor's bill would repeal the ban on "post-claims underwriting" in Health & Safety Code Section 1389.3 which bars health insurers from rescinding or limiting a policy in anyway after a patient gets sick unless the insurer can show that the patient "willfully misrepresented" a material health fact on their enrollment application.

Download the governor's bill here: http://www.ConsumerWatchdog.org/resources/Gov.pdf

Given the extreme hardship placed on patients whose coverage has been retroactively
'/>"/>

SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Consumers, Health Care Purchasers Applaud Agreement On Physician Performance Reporting
2. Quixtar Files Suit Against MonaVie To Protect Consumers, Halt Unfair Competition
3. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
4. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
5. Life Denied: California Nurses, Family of Sick Teen March on Health Insurance Company Thursday
6. Pennsylvania Governor Rendell Announces $1.8 Million Investment to Add Nurses, Improve Nurse Education Grants Awarded to Recipients in 28 Counties
7. Life Denied: Nurses, Family of Sick Teen March on Health Insurance Company Tuesday
8. Nationwide Awards Recognize Nurses, Associates and Nursing Teams That Specialize in Gastroenterology and Endoscopy
9. Fathers Day is Almost Here: Two Pediatric Nurses, Moms, Offer Practical Guidebook & DVD for New Dads
10. Nurses, Doctors, Patients to Protest Health Insurers at National Day of Action - June 19th
11. Nurses, Doctors, Patients to Protest Health Insurers on National Day of Action - June 19th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ls about how proteins used to destroy bacteria and...nar K. Gouras, associate professor of neurology an... University, New York, and colleagues provide new ...alled antibodies, reduce the main hallmarks of Alz...
... scientific method for testing and measuring xanth...nducted on XanGo Juice , indicate usage of the who... high xanthone absorption. XanGo, LLC, recognized...t category is leading scientific exploration of th...
...ng all possible arrangements to look good on her y...o sources, the first thing that the socialite will... dry face. Hilton has resentfully complained to t...that she's not permitted to have facial moisturize...
...y who were destined to go blind within five years ...treatment with Avastin , a well-known cancer drug,...ne, 2007 Archives of Ophthalmology. This is a majo...ts who are treated with radiation therapy and comm...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3Health News:Untreatable Eye Disease Improves With Avastin 2
(Date:8/25/2008)...t and Japanese Development Studies ...ust 25 /- Genmab has,announ...hronic lymphocytic,leukemia and non-Hodgkin,s lymp...s to begin four studies of,ofatumumab in chronic l...in,s lymphoma (NHL) this year., "Genmab and GSK h...
(Date:8/22/2008)...FirstCall/ -- Human Genome,Sciences, Inc. (Nasdaq:...,enrollment and initial dosing of patients in a ra...n combination with the chemotherapy agents,paclita...ced non-small cell,lung cancer (NSCLC)., (Logo: ...GO ), "There is an urgent medical need for effec...
(Date:8/21/2008)...-USNewswire/ -- Dangerous disease,often spreads fa...emedy,that, researchers at Kansas State University...s down to hours., Sanjeev Narayanan, assistant pr...t, both in the department of diagnostic medicine a... microarray to seek out the,specific genetic marke...
(Date:8/21/2008)...re-FirstCall/ -- Telik, Inc.,(Nasdaq: TELK ) anno...me,inhibitor program met a preclinical development... preclinical models of human leukemia. The proteas...or the growth and function of,cancer cells and inh...e,cell cycle arrest and cancer cell death or apopt...
Breaking Medicine Technology:Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone 2To catch a panda 1538 1To catch a panda 1538 2Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 1Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 2CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 1CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 1New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 3
...fficacy in broad range,of patients and across cont.../PRNewswire-FirstCall/ --,Millennium Pharmaceutica...e market leading therapy with unsurpassed single-a... multiple myeloma,(MM), will be featured at the up..., Greece, June 25-30, 2007. , "Clinical data to be...
...ll/ -- Vical,Incorporated today announced that the...ive results following interim analysis of data,fro...l of an,angiogenesis product candidate using Vical...that the primary efficacy,endpoint in the trial ha...that there were no major safety concerns related,t...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
Medicine Products: